Jellatech Announces $3.5M Oversubscribed Seed Round
August 22, 2023
Raleigh-based biotechnology company Jellatech announces a $3.5M oversubscribed Seed Round to enable scale-up of their cutting-edge protein manufacturing platform.
JELLATECH OFFICIAL PRESS RELEASE: DEVELOPMENT OF CELL BASED HUMAN COLLAGEN
MARCH 3, 2023
Jellatech announces a new major milestone achievement - the development of cell based human collagen.
JELLATECH SHOWCASES CELL-BASED COLLAGEN
June 27, 2022
Today, June 27th 2022, North Carolina-based biotech startup Jellatech announces its major milestone achievement in producing cell-based collagen.
CULT FOOD SCIENCE AFFILIATE PRODUCES ITS FIRST CELL-BASED COLLAGEN
July 6, 2022
After two years of research and development, Jellatech has successfully developed full-length, triple-helical and functional collagen made from its own proprietary cell lines. CULT's affiliate has worked to produce collagen that is bio-identical to native collagen but does not require the use of animals in its production.
CANADA: CULT ANNOUNCES STRATEGIC INVESTMENT IN CULTIVATED COLLAGEN & GELATIN PIONEER JELLATECH
February 1, 2022